Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 5 of 5 citing Melander: Kinetics-Effect Relations of Insulin-Releasing Drugs in Patients With Type 2 Diabetes. (0.07 sec) 

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter ( …

- aspetjournals.org
K Katsuno, Y Fujimori, Y Takemura, M Hiratochi, F … - Journal of Pharmacology …, 2007 - ASPET
The low-affinity sodium glucose cotransporter (SGLT2), which is expressed specifically in the
kidney, plays a major role in renal glucose reabsorption in the proximal tubule. We have discovered
sergliflozin, a prodrug of a novel selective SGLT2 inhibitor, based on benzylphenol ...
Cited by 31 - Related articles - All 5 versions

Nitric oxide involvement in pancreatic β cell apoptosis by glibenclamide


MM Ansar, M Ansari - Nitric Oxide, 2006 - Elsevier
Glibenclamide as a second-generation compound of sulfonylurea has widely been used in the
treatment of type 2 diabetes patients. It has been shown that it induces apoptosis in β cells, which
is partially mediated by Ca 2+ influx. Here, we investigated the role of nitric oxide (NO) ...
Cited by 8 - Related articles - All 3 versions

Dose-Response Relationships of Sulfonylureas: Will Doubling the Dose Double …


V Rambiritch, P Naidoo, N Butkow - Southern Medical Journal, 2007 - journals.lww.com
Abstract: type 2 diabetes mellitus is currently a global health prob- lem. Although the armamentarium
of oral hypoglycemic agents is continuously expanding, sulfonylureas (SUs) are still extensively
used for the management of type 2 diabetes mellitus. However, despite decades of use, ...
Cited by 2 - Related articles - BL Direct - All 3 versions

Gliclazide Modified Release.


V Rambiritch, P Naidoo - Drugs, 2005 - pt.wkhealth.com
Gliclazide MR is approximately three times more costly when compared with generic gliclazide
CR (manufacturer's price list). However, for patients requiring >160 mg/day of the gliclazide CR
preparation, and who are poorly compliant on twice-daily regimens as compared with ...
Cited by 1 - Related articles - BL Direct - All 3 versions

Effects of gliclazide dose escalation on postprandial hyperglycemia in type 2 …


P Naidoo, R Virendra, M Layla - Current Therapeutic Research, 2006 - Elsevier
Methods: This prospective, open-label, case-controlled, dose-escalation study was conducted
at the Addington Hospital Diabetes Clinic, eThekwini/Durban, KwaZulu-Natal, South Africa. Male
and female patients aged ≥18 years with type 2 diabetes mellitus (DM) and postprandial ...
Cited by 1 - Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google